Creative Medical Technology Holdings, Inc. Share Price
NASDAQ: CELZ | Micro CapCreative Medical Technology Holdings, Inc. Stock Performance
Creative Medical Technology Holdings, Inc. Share Price Chart
Creative Medical Technology Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Creative Medical Technology Holdings, Inc. Annual Profit & Loss
All figures in USD
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Creative Medical Technology Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.94 | $0.71 | -23.96% |
Sep 2026 | $1.10 | $0.94 | -17.98% |
Aug 2026 | $0.64 | $1.14 | +67.40% |
Jul 2026 | $1.32 | $0.68 | -51.70% |
Jun 2026 | $2.27 | $1.41 | -39.22% |
May 2026 | $2.23 | $2.32 | +6.18% |
Apr 2026 | $1.99 | $2.19 | +6.07% |
Mar 2026 | $1.85 | $2.06 | +13.81% |
Feb 2026 | $1.93 | $1.81 | -7.65% |
Jan 2026 | $2.04 | $1.96 | +1.55% |
Dec 2025 | $2.67 | $1.93 | -28.25% |
Nov 2025 | $3.16 | $2.69 | -14.06% |